Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203846) titled 'Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Collegium Medicum w Bydgoszczy
Condition:
ACS - Acute Coronary Syndrome
Ticagrelor
Microbiota
Platelet Aggregation
Myocardial Infarction (MI)
Blood Platelets
Drug Effects
Platelet Aggregation Inhibitors
Drug Resistance
Platelet Function Tests
Dysbiosis
Anti-Bacterial Agents
Rifaximin
Intervention:
Drug: Rifaximin...